XPH
State Street SPDR S&P Pharmaceuticals ETF
Price Chart
Latest Quote
$68.60
+1.30 (+1.93%)
Current Price
| Previous Close | $67.30 |
| Open | $66.83 |
| Day High | $68.60 |
| Day Low | $66.84 |
| Volume | 4,421 |
Fund Information
| Quarterly Dividend / Yield | N/A / 0.51% |
| Shares Outstanding | 5.50M |
| Net Assets | $428.43M |
| Expense Ratio | 0.35% |
| Category | Health |
| Fund Family | State Street Investment Management |
| Net Asset Value | $67.86 |
| Premium/Discount | 1.09% |
| Quarterly Dividend Yield | 0.51% |
| P/E Ratio | 18.13 |
| Exchange | PCX |
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-07-17 | $68.58 | 48,600 |
| 2026-07-16 | $67.30 | 56,100 |
| 2026-07-15 | $67.96 | 34,400 |
| 2026-07-14 | $67.16 | 58,700 |
| 2026-07-13 | $66.82 | 111,800 |
| 2026-07-10 | $68.44 | 88,100 |
| 2026-07-09 | $70.05 | 58,900 |
| 2026-07-08 | $69.40 | 231,600 |
| 2026-07-07 | $69.83 | 245,300 |
| 2026-07-06 | $67.28 | 300,600 |
| 2026-07-02 | $67.16 | 87,100 |
| 2026-07-01 | $65.32 | 119,000 |
| 2026-06-30 | $66.27 | 187,600 |
| 2026-06-29 | $66.41 | 99,500 |
| 2026-06-26 | $65.92 | 283,800 |
| 2026-06-25 | $64.53 | 199,500 |
| 2026-06-24 | $64.45 | 57,200 |
| 2026-06-23 | $63.21 | 190,000 |
| 2026-06-22 | $62.11 | 112,700 |
| 2026-06-18 | $60.98 | 35,600 |
About State Street SPDR S&P Pharmaceuticals ETF
In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI").
📰 Latest News
Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?
Zacks • 2026-06-05T10:20:03Z
Should You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)?
Zacks • 2026-06-03T10:20:02Z
These 5 Undervalued ETFs Could Be Bargains Right Now
24/7 Wall St. • 2026-02-26T12:55:24Z
XPH’s 29% Run Looks Tempting, But The 5y Chart Is A Warning
24/7 Wall St. • 2026-02-18T16:58:50Z
Biopharma 2026 outlook: Keep an eye out for M&A
Yahoo Finance Video • 2025-12-24T11:30:06Z3 Undervalued ETFs to Buy Before 2026
Zacks • 2025-12-10T12:00:00Z
Pharma ETF (XPH) Hits a New 52-Week High
Zacks • 2025-12-09T11:00:00Z
Pharma ETFs in Spotlight Following Robust Q3 Earnings Results
Zacks • 2025-11-14T12:59:00Z
4 Reasons to Buy Pharma ETFs Now for a Healthy Portfolio
Zacks • 2025-10-06T10:57:00Z
Biopharma Stocks Rally After Trump Threatens 100% Pharmaceuticals Tariff
Investor's Business Daily • 2025-09-26T20:22:07Z
Period:
Loading...
No financial data available yet. Financial data will be fetched automatically.